Status | Study |
RECRUITING |
Study Name: Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS Condition: Hemorrhagic Fever With Renal Syndrome Date: 2020-12-24 Interventions: Based upon clinical classification of HFRS , the patients were classified into four types |
Recruiting |
Study Name: Diagnostic of Puumala Virus Infection in France Condition: Nephropathia Epidemica Hemorrhagic Fever With Renal Syndrome Date: 2015-04-21 |
Completed |
Study Name: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS Condition: Infection Date: 2015-02-03 Interventions: Drug: Hantavax injection Intramuscular or hypodermic injection of 0.5ml per time twice at interval of 1 |
Active, not recruiting |
Study Name: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Condition: Hemorrhagic Fever With Renal Syndrome Date: 2014-04-14 Interventions: Biological: HTNV/PUUV DNA vaccine |
Completed |
Study Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Condition: Hemorrhagic Fever With Renal Syndrome Date: 2011-12-23 Interventions: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |
Withdrawn |
Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany Condition: Hemorrhagic Fever With Renal Syndrome Date: 2009-03-24 Interventions: Drug: Virazole (Ribavirin) Duration of Subject Participati |
Enrolling by invitation |
Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome Condition: Hemorrhagic Fever With Renal Syndrome Date: 2008-02-13 Interventions: Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day |